platelet-rich plasma (Buddhist Tzu Chi General Hospital)

This is an investigational autologous platelet-rich plasma (PRP) therapy developed by **Buddhist Tzu Chi General Hospital** (Hualien Tzu Chi Hospital) for the treatment of refractory **interstitial cystitis/bladder pain syndrome (IC/BPS)**. The therapy involves extracting PRP from the patient's own whole blood and administering it via intravesical injections directly into the bladder wall. PRP is a concentrated source of autologous growth factors—including PDGF, VEGF, and TGF-beta—and cytokines that are believed to facilitate tissue reconstruction and regeneration of the damaged bladder urothelium. Clinical studies led by Dr. Hann-Chorng Kuo have evaluated its safety and efficacy in patients who have failed conventional treatments, showing improvements in pain scores and bladder capacity.

Other names

PRPautologous platelet-rich plasmaintravesical platelet-rich plasma